UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000046238 |
|---|---|
| Receipt number | R000052763 |
| Scientific Title | Examination of the effects of the test food intake on energy metabolism |
| Date of disclosure of the study information | 2021/12/03 |
| Last modified on | 2023/06/12 08:12:45 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Examination of the effects of the test food intake on energy metabolism
Acronym
Examination of the effects of the test food intake on energy metabolism
Scientific Title
Examination of the effects of the test food intake on energy metabolism
Scientific Title:Acronym
Examination of the effects of the test food intake on energy metabolism
Region
| Japan |
Condition
Condition
Healthy volunteers
Classification by specialty
| Not applicable | Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To examine the effects of single intake of test foods on energy expenditure, oxygen consumption, fat consumption, carbohydrate consumption and respiratory quotient
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
energy expenditure and respiratory quotient
Key secondary outcomes
oxygen consumption, fat consumption and carbohydrate consumption
Base
Study type
Interventional
Study design
Basic design
Cross-over
Randomization
Randomized
Randomization unit
Individual
Blinding
Double blind -all involved are blinded
Control
Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
2
Purpose of intervention
Prevention
Type of intervention
| Food |
Interventions/Control_1
Single intake of the test food -> washout period (1 week) -> Single intake of the placebo
Interventions/Control_2
Single intake of the placebo -> washout period (1 week) -> Single intake of the test food
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 35 | years-old | >= |
Gender
Male
Key inclusion criteria
1) Males whose age of 20 to 35 years
2) BMI>=18.5 kg/m2 and <23.0 kg/m2
3) Subjects receiving a sufficient briefing of the objective and content of the present study, fully understanding and agreeing to voluntarily participate in the study and being able to personally sign a written informed consent
4) Subjects who can participate in the examination at the specified date and time
Key exclusion criteria
1) Subjects receiving a medical treatment for serious cardiovascular, hepatic, renal, respiratory, endocrine or metabolic disorders or having a medical history of these disorders
2) Subjects having a medical history of chest pain or syncope
3) Subjects having a subjective symptom of low back pain, arthralgia or lumber hernia, disease of lower limbs, palpitations
4) Subjects who have the possibility of developing allergic symptoms by the test food
5) Subjects who take regularly medicines and quasi-drugs having the effect on energy metabolism
6) Subjects who take regularly Foods for Specified Health Uses or Foods with Function Claims labeled the effect on energy metabolism
7) Subjects who have a smoking habit
8) Subjects who work the night shift
9) Subjects having blood sample of 200 ml or more taken within 1 month, or 400 ml or more within 3 months prior to the start of the present study (e.g. donated blood)
10) Subjects who took part in another clinical study within 3 months prior to the start of the present study or who is currently taking part in another clinical study
11) Subjects deemed unsuitable by the investigator
Target sample size
24
Research contact person
Name of lead principal investigator
| 1st name | Takashi |
| Middle name | |
| Last name | Tagawa |
Organization
Maruzen Pharmaceuticals Co., Ltd
Division name
Research & Development Division
Zip code
729-3102
Address
1089-8, Shinichi-cho Sagata, Fukuyama, Hiroshima
TEL
0847-52-6262
t-tagawa@maruzenpcy.co.jp
Public contact
Name of contact person
| 1st name | Tomohiro |
| Middle name | |
| Last name | Sugino |
Organization
Soiken Inc.
Division name
R&D Division
Zip code
560-0082
Address
Senri Life Science Center 13F, 1-4-2, Shinsenri-higashimachi, Toyonaka, Osaka
TEL
06-6871-8888
Homepage URL
sugino@soiken.com
Sponsor or person
Institute
Senri Life Science Center 13F, 1-4-2, Shinsenri-higashimachi, Toyonaka, Osaka
Institute
Department
Personal name
Funding Source
Organization
Maruzen Pharmaceuticals Co., Ltd
Organization
Division
Category of Funding Organization
Profit organization
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
IRB of Fukuda Clinic
Address
Shin-Osaka Brick Building 2F, 1-6-1, Miyahara, Yodogawa-ku, Osaka, Osaka
Tel
06-6398-0203
fukudaclinicIRB@gmail.com
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2021 | Year | 12 | Month | 03 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2021 | Year | 09 | Month | 18 | Day |
Date of IRB
| 2021 | Year | 09 | Month | 18 | Day |
Anticipated trial start date
| 2021 | Year | 12 | Month | 05 | Day |
Last follow-up date
| 2022 | Year | 02 | Month | 27 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2021 | Year | 11 | Month | 30 | Day |
Last modified on
| 2023 | Year | 06 | Month | 12 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000052763
